Latest: Q2 2026 · from the cash-flow statements filed with the SEC
Free cash flow−$9.6M in Q2 2026 · −$25.8M over twelve months
Operating cash flow−$9.2M
Capital spending−$321K
Free cash flow−$9.6M
Analysis
In Q2 2026, DocGo generated −$9.2M of operating cash flow and spent $321K on capital projects, leaving free cash flow of −$9.6M. That is $42.5M less than in Q2 2025 ($32.9M).
Over the twelve months to Jun 30, 2026, operating cash flow was −$22.7M; the largest uses were other financing ($31.6M), operating cash flow ($22.7M), acquisitions ($12.7M); besides operations, cash came from other investing ($1.6M), asset & business sales ($69K); the cash balance fell by $76.4M.
Operating cash flow was −$9.2M against net income of −$18.0M. The largest differences: receivables +$6.6M, accrued liabilities −$4.5M, depreciation & amortization +$2.7M.
Free cash flow
Operating cash flow less capital spending.Latest (Q2 2026): Operating cash flow −$9.2M, Capital spending $321K.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $67.0M; the largest uses were capital spending ($172M) and acquisitions ($70.9M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$25.2M
Debt$207K
Net cash$25.0M
Due within a year$52K
Cash runway12 months
DocGo is burning cash: its operations consume cash, a free cash flow of −$25.8M a year at the current rate against $25.2M of cash and investments: a runway of about 12 months; $52K of debt also comes due within a year, which would need refinancing or new money before any new financing.
Principal due in each year as disclosed in the annual report, against $25.2M of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Every quarter
Quarter
Operating cash flow
Capital spending
Acquisitions
Buybacks
Net borrowing (+) / repaid (−)
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q2 2026
−$9.2M
−$321K
—
—
−$1.6M
—
$14.6M
−$9.6M
Q1 2026
−$4.7M
−$430K
—
—
−$1.4M
—
$5.7M
−$5.1M
Q4 2025
−$10.5M
−$1.5M
−$12.7M
—
−$1.4M
—
$25.1M
−$12.0M
Q3 2025
$1.7M
−$876K
—
—
−$31.3M
—
$30.9M
$783K
Q2 2025
$34.0M
−$1.1M
—
−$5.1M
−$1.4M
—
−$5.5M
$32.9M
Q1 2025
$9.2M
−$1.0M
−$3.6M
−$5.8M
−$1.3M
—
$4.3M
$8.2M
Q4 2024
$12.7M
−$725K
—
−$2.7M
−$1.2M
$26K
$1.2M
$12.0M
Q3 2024
$31.1M
−$4.2M
—
−$1.3M
−$1.1M
—
−$22.8M
$26.9M
DocGo: income statement and cash flow
DocGo, Q2 2026: revenue $73.4M (-9% year over year), operating margin -24.4%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.